Mucormycosis infection in patients with COVID ‐19: A systematic review (original) (raw)

Mucormycosis infection in patients with COVID ‐19: A systematic review

Health Science Reports, 2022

Abstract

Several reports previously described mucormycosis co‐infection in patients with COVID‐19. As mucormycosis and COVID‐19 co‐infection might adversely affect patients' outcomes, we aimed to systematically review the related evidence and the subsequent outcomes.

Marcarious Moorkereh hasn't uploaded this paper.

Let Marcarious know you want this paper to be uploaded.

Ask for this paper to be uploaded.